ITGB2 and neoplasm: As broadly depicted in Figure 3, these disruptions generally affect anti-tumor immune functions by impairing leukocyte adhesion to tumor vasculature, infiltration into tumors, the formation of functional immunological synapses, and the destruction of malignant cells, while also exploiting LFA-1 to promote metastasis.